Phase 2 CMV Infection Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

EBV InfectionCMV InfectionBKV Infection

LucasBio27 enrolled1 locationNCT07670468

Recruiting

Phase 1Phase 2

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

TuberculosisEBV InfectionAdenovirus Infection+4 more

Shenzhen Geno-Immune Medical Institute100 enrolled1 locationNCT03159364

Recruiting

Phase 2

Study Evaluating the Efficacy and Safety of Artesunate

CMV Infection

Amivas Inc.90 enrolled4 locationsNCT06853184